3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Suspended
1
Active not recruiting
1
Sponsor
Conditions
Pancreatic Neoplasms
17
Carcinoma, Non-Small-Cell Lung
9
Triple Negative Breast Neoplasms
8
Lung Neoplasms
7
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Esophageal Squamous Cell Carcinoma
3
Stomach Neoplasms
2
Pancreatic Adenocarcinoma
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Advanced Solid Tumor
2
Uterine Cervical Neoplasms
1
Squamous Cell Non-small Cell Lung Cancer
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Neoplasms, Basal Cell
1
Muscle-Invasive Bladder Carcinoma
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Lymphoma
1
Locally Advanced or Metastatic Solid Tumors
1
Locally Advanced Pancreatic Cancer
1
Interventions
Oxaliplatin
6
Gemcitabine
6
Cisplatin
4
durvalumab
3
pembrolizumab
2
Leucovorin
2
Drug Therapy
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
sintilimab
1
pertuzumab
1
fludarabine
1
atezolizumab
1
anlotinib
1
Trastuzumab
1
Standard of Care
1
Observation
1
Nivolumab
1
Neoadjuvant Therapy
1
Long-Term Synaptic Depression
1
Irinotecan
1
Folfox protocol
1
Fluorouracil
1
Everolimus
1
Cyclophosphamide
1
Commerce
1
Cholangiopancreatography, Endoscopic Retrograde
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Gallbladder Neoplasms
×
Albumin-Bound Paclitaxel
×
Clear all
No trials found.